The use of vitamin D supplementation and risk of hypercalciuria
Not Applicable
- Conditions
- Condition 1: urolithiasis. Condition 2: vitamin D deficiency.Calculus of kidney and ureterVitamin D deficiency, unspecified
- Registration Number
- IRCT20180108038262N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
urinary stone former
vitamin D defficiency
sign the constant form
Exclusion Criteria
pregnant patients
hypercalcemia (baseline calcium level of =10.4 mg/dl)
medications that affect calcium and bone metabolism (such as calcium) or calcium excretion (such as steroidal or hormonal drugs),
previous history of primary hyperparathyroidism or other systemic diseases (cancer, alcoholic liver disease and osteoporosis)
patients who had invasive diagnostic or therapeutic interventions on renal stones within the last month prior to enrollment
known case of uric acid ,cysteine or steruvite urinary stone
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of increase in urinary calcium. Timepoint: before and after 3 month of vitamin D prescription. Method of measurement: measurement of calcium in 24 hour urine.;Urinary stone formation. Timepoint: 3 month after treatment. Method of measurement: ultrasound examination.
- Secondary Outcome Measures
Name Time Method Serum parathyroid change. Timepoint: before and 3 month after vitamin D prescription. Method of measurement: laboratory measurment.